Journal of Neuroinflammation (Feb 2023)

Inducible co-stimulatory molecule (ICOS) alleviates paclitaxel-induced neuropathic pain via an IL-10-mediated mechanism in female mice

  • Ishwarya Sankaranarayanan,
  • Diana Tavares-Ferreira,
  • Juliet M. Mwirigi,
  • Galo L. Mejia,
  • Michael D. Burton,
  • Theodore J. Price

DOI
https://doi.org/10.1186/s12974-023-02719-8
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 15

Abstract

Read online

Highlights ICOS agonist antibody (ICOSaa) promotes paclitaxel-evoked pain resolution in female mice. DRG T cells appear to enter an anti-inflammatory phenotype by ICOSaa treatment. ICOSaa treatment increases DRG levels of IL-10 cytokine. ICOSaa effects in female mice are blocked by IL-10 sequestering treatment.

Keywords